Through collaboration with European health bodies, Global Health EDCTP3 aims to strengthen tuberculosis prevention and treatment, especially involving children and people with weakened immune systems

Europe is striving to be a prime location for testing and bringing new medicines to market, but experts say fragmentation, inconsistent interpretation of legislation, and lack of incentives stand in the way.

Launched in 2003 in response to the Millennium Development Goals and more recently the Sustainable Development Goals, the European & Developing Countries Clinical Trials Partnership (EDCTP) has supported groundbreaking innovations like paediatric HIV and tuberculosis medicines, malaria vaccines and treatments, as well as treatments for neglected tropical diseases. These advances are saving and improving lives and strengthening global health security.

Co-authored by: 
Martin Fitchet, Executive Director of Medicines for Malaria Venture (MMV), 
Luis Pizarro, Executive Director of the Drugs for Neglected Diseases Initiative (DNDi), and 
Marina Gold, Executive Director of Mundo Sano.